Pulmonary Rehabilitation
OtherExercise training+ Optimal medication and clinical follow-up
NCT Number: NCT04347044
The data of patients undergoing bronchoscopic volume reduction procedure will be analyzed retrospectively. Patients will be divided into two groups as patients with and without Pulmonary Rehabilitation before the procedure, and changes in functional levels of patients will be compared.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
The data of patients who underwent bronchoscopic volume reduction between January 2013 and March 2019 will be examined.
Patients will be divided into two groups as pulmonary rehabilitation applied (PR group) and not applied (Control group) before the procedure.
Changes in the parameters of initial and rehabilitation follow-up will be examined.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exercise training+ Optimal medication and clinical follow-up
Optimal medication and clinical follow-up
Time frame: 20 minutes
The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were asked to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating were measured, and the walking distance were recorded
Time frame: 15 minutes
PFTs were performed by using the Sensormedics model 2400 (Yorba Linda, CA, USA) spirometry device, and according to the American Thoracic Society (ATS) guidelines
Time frame: 15 minutes
It will performed in the pulmonary function test laboratory using Cosmed Quark PFT (USA) with single-breath technique
Istanbul Medipol University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02999685
Chronic Disease, Chronic Obstructive Pulmonary Disease
Rochester, Minnesota, United States
View Trial DetailsNCT03518177
Bronchoscopic Lung Volume Reduction, Emphysema
Istanbul, Zeytinburnu, Turkey (Türkiye)
View Trial DetailsNCT05567562
COPD, Chronic Disease
Boston, Massachusetts, United States
View Trial DetailsNCT05550844
Emphysema, Pathologic Processes
Lille, Hauts-de-France, France
View Trial Details